These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2393054)

  • 1. Effects and limitations of pentoxifylline therapy in various stages of peripheral vascular disease of the lower extremity.
    AbuRahma AF; Woodruff BA
    Am J Surg; 1990 Sep; 160(3):266-70. PubMed ID: 2393054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pentoxifylline on severe intermittent claudication.
    Reich T; Gillings D
    Angiology; 1987 Sep; 38(9):651-6. PubMed ID: 3310744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent claudication: a double-blind crossover trial of pentoxifylline.
    Gallus AS; Gleadow F; Dupont P; Walsh J; Morley AA; Wenzel A; Alderman M; Chivers D
    Aust N Z J Med; 1985 Aug; 15(4):402-9. PubMed ID: 3866536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.
    Dettori AG; Pini M; Moratti A; Paolicelli M; Basevi P; Quintavalla R; Manotti C; Di Lecce C
    Angiology; 1989 Apr; 40(4 Pt 1):237-48. PubMed ID: 2650578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentoxifylline in the treatment of intermittent claudication of the lower limbs.
    Reich T; Cutler BC; Lee BY; Porter JM; Reichle FA; Scogin JT; Strandness DE
    Angiology; 1984 Jul; 35(7):389-95. PubMed ID: 6380347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of response to pentoxifylline therapy in patients with intermittent claudication.
    Thomas JH; Swannack CJ; McAnaw M; Klein S; Kinnaman ML; Iliopoulos JI; Hermreck AS; Pierce GE
    Am J Surg; 1987 Dec; 154(6):663-5. PubMed ID: 3425814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication.
    Crowder JE; Cohn JB; Savitsky JP; Morgan DL; Slywka J; Cobert BL; Hryniewicki SW; Piccirillo RT; Wilcox CS
    Angiology; 1989 Sep; 40(9):795-802. PubMed ID: 2669564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentoxifylline in the nonoperative management of intermittent claudication.
    Kokesh J; Kazmers A; Zierler RE
    Ann Vasc Surg; 1991 Jan; 5(1):66-70. PubMed ID: 1997079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic treatment of intermittent claudication.
    Porter JM; Bauer GM
    Surgery; 1982 Dec; 92(6):966-71. PubMed ID: 7147192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photoplethysmographic documentation of improved microcirculation after pentoxifylline therapy.
    Roeren T; LeVeen RF; Nugent L
    Angiology; 1988 Nov; 39(11):929-33. PubMed ID: 3177959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral vasodilators versus pentoxifylline for the treatment of intermittent claudication.
    Aviado DM
    Ric Clin Lab; 1983; 13 Suppl 3():263-8. PubMed ID: 6143383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients.
    Porter JM; Cutler BS; Lee BY; Reich T; Reichle FA; Scogin JT; Strandness DE
    Am Heart J; 1982 Jul; 104(1):66-72. PubMed ID: 7046409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentoxifylline treatment of moderate to severe chronic occlusive arterial disease.
    Lee BY; Berkowitz P; Savitsky JP; May GS; Brobst J; McCann WJ
    Clin Cardiol; 1985 Mar; 8(3):161-5. PubMed ID: 3978888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentoxifylline increases extremity blood flow in diabetic atherosclerotic patients.
    Schwartz RW; Logan NM; Johnson PJ; Strodel WE; Fine JG; Kazmers A; Hyde GL
    Arch Surg; 1989 Apr; 124(4):434-7. PubMed ID: 2649042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline.
    Rudofsky G; Haussler KF; Künkel HP; Schneider-May H; Spengel F; Symann O; Werner HJ
    Angiology; 1989 Jul; 40(7):639-49. PubMed ID: 2662830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentoxifylline--a new drug for the treatment of intermittent claudication.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Scandinavian Study Group.
    Lindgärde F; Jelnes R; Björkman H; Adielsson G; Kjellström T; Palmquist I; Stavenow L
    Circulation; 1989 Dec; 80(6):1549-56. PubMed ID: 2688972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Another look at the pentoxifylline efficacy data for intermittent claudication.
    Gillings D; Koch G; Reich T; Stager WJ
    J Clin Pharmacol; 1987 Aug; 27(8):601-9. PubMed ID: 3655008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intermittent claudication treated with pentoxifylline. A controlled trial].
    Skovborg F; Bonde-Petersen F; Bloch I; Christensen E
    Ugeskr Laeger; 1983 Nov; 145(47):3649-52. PubMed ID: 6362159
    [No Abstract]   [Full Text] [Related]  

  • 20. Pentoxifylline: a new agent for intermittent claudication.
    Baker DE; Campbell RK
    Drug Intell Clin Pharm; 1985 May; 19(5):345-8. PubMed ID: 3891279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.